首页> Nature medicine> Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

导出原文传递

翻译打印收藏纠错

第一作者： Jordan R Barrett

作者： Jordan R Barrett ^[1] ; Sandra Belij-Rammerstorfer ^[2] ; Christina Dold ^[3] ; Katie J Ewer ^[4] ; Pedro M Folegatti ^[5] ; Ciaran Gilbride ; Rachel Halkerston ; Jennifer Hill ; Daniel Jenkin ; Lisa Stockdale ; Marije K Verheul ; Parvinder K Aley ; Brian Angus ; Duncan Bellamy ; Eleanor Berrie ; Sagida Bibi ; Mustapha Bittaye ; Miles W Carroll ; Breeze Cavell ; Elizabeth A Clutterbuck ; Nick Edwards ; Amy Flaxman ; Michelle Fuskova ; Andrew Gorringe ; Bassam Hallis ; Simon Kerridge ; Alison M Lawrie ; Aline Linder ; Xinxue Liu ; Meera Madhavan ; Rebecca Makinson ; Jack Mellors ; Angela Minassian ; Maria Moore ; Yama Mujadidi ; Emma Plested ; Ian Poulton ; Maheshi N Ramasamy ; Hannah Robinson ; Christine S Rollier ; Rinn Song ; Matthew D Snape ; Richard Tarrant ; Stephen Taylor ; Kelly M Thomas ; Merryn Voysey ; Marion E E Watson ; Daniel Wright ; Alexander D Douglas ; Catherine M Green ; Adrian V S Hill ; Teresa Lambe ; Sarah Gilbert ; Andrew J Pollard ; Oxford COVID Vaccine Trial Group

作者单位： Oxford Vaccine Group, Department of Paediatrics, University of Oxford ^[1] Nuffield Department of Medicine, University of Oxford ^[2] Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine ^[3] Public Health England ^[4] The Jenner Institute, Nuffield Department of Medicine, University of Oxford ^[5]

发布时间 2021-12-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交